Financial Performance - The company's operating revenue for 2025 reached ¥23.21 billion, a 38.32% increase compared to ¥16.78 billion in 2024[24]. - Total profit for 2025 was ¥2.87 billion, reflecting a 45.06% growth from ¥1.98 billion in 2024[24]. - Net profit attributable to shareholders was ¥1.78 billion, up 16.29% from ¥1.53 billion in 2024[24]. - The net cash flow from operating activities increased by 75.31% to ¥6.34 billion in 2025, compared to ¥3.62 billion in 2024[24]. - The company's total assets as of the end of 2025 were ¥43.88 billion, a 25.62% increase from ¥34.93 billion at the end of 2024[24]. - The net asset attributable to shareholders increased by 34.01% to ¥16.86 billion at the end of 2025, compared to ¥12.58 billion at the end of 2024[24]. - Basic earnings per share for 2025 were ¥0.686, a decrease of 3.79% from ¥0.713 in 2024[25]. - The company completed a private placement of 597,269,624 shares at a price of ¥5.86 per share, raising approximately ¥3.50 billion in gross proceeds[25]. Dividend Distribution - The company plans to distribute cash dividends of RMB 3.25 per 10 shares, totaling RMB 891,774,128.38 based on the total share capital of 2,743,920,395 as of December 31, 2025[7]. - The cumulative cash dividend over the last three accounting years is RMB 2,189,697,309.80, with a cash dividend ratio of 150.16% based on the average annual net profit[176]. Audit and Compliance - The company has received a standard unqualified audit report from Lixin Certified Public Accountants[6]. - The board of directors has confirmed the authenticity, accuracy, and completeness of the annual report[4]. - There are no non-operating fund occupations by controlling shareholders or related parties[9]. - The company has not violated decision-making procedures for external guarantees[9]. - The company has not disclosed any significant changes in shareholder structure or bond-related situations[11]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties during the reporting period[198]. - There were no violations of guarantees reported during the period[198]. - The company has not encountered any significant accounting errors or changes in accounting policies during the reporting period[199]. Risk Management - The company has detailed potential risks in the management discussion and analysis section of the report[10]. - The company emphasizes that forward-looking statements do not constitute substantive commitments to investors[8]. - The company is facing macroeconomic and geopolitical risks, with uncertainties in global economic recovery and potential disruptions in supply chains due to regional conflicts[133]. - Market supply and demand fluctuations may lead to price volatility, prompting the company to strengthen strategic partnerships with core clients and enhance market research capabilities[134]. - Stricter environmental regulations are increasing operational costs related to fleet upgrades and compliance, prompting the company to integrate green practices into its management[135]. - Rising fuel prices due to geopolitical tensions may impact costs, leading the company to implement flexible pricing mechanisms and bulk purchasing strategies to mitigate risks[136]. Fleet and Operations - The company reported a total of 198 vessels with a combined deadweight tonnage of 9.1185 million tons by the end of 2025[37]. - The multi-purpose vessel segment generated revenue of CNY 4.091 billion in 2025, a year-on-year increase of 13.16%, with a gross margin of 17.38%[38]. - The new multi-purpose vessel segment achieved revenue of CNY 5.957 billion, reflecting a 35.15% year-on-year growth, with a gross margin of 13.05%[39]. - The semi-submersible vessel segment's revenue reached CNY 2.895 billion, up 9.82% year-on-year, with a gross margin of 26.74%[39]. - The automotive vessel segment saw a significant revenue increase to CNY 4.401 billion, a 213.59% rise year-on-year, with a gross margin of 30.42%[40]. - The asphalt vessel segment reported revenue of CNY 531 million, a 10.38% increase year-on-year, with a gross margin of 21.95%[40]. - The wood vessel segment's revenue decreased to CNY 494 million, down 14.36% year-on-year, with a gross margin of 0.62%[40]. - The company is actively expanding its fleet with new vessel orders, including 7 new semi-submersible vessels to strengthen its operational capabilities[39]. Strategic Partnerships and Market Expansion - The company signed multiple COA transportation agreements with leading industry clients, enhancing market share and customer loyalty[38]. - The company has signed a strategic cooperation agreement with SAIC Anji Logistics to optimize capacity allocation and improve operational efficiency in international automotive shipping[42]. - The company established strategic partnerships with key ports, forming a supply chain network centered around Qingdao, Shanghai, and Guangzhou[65]. - The company is focusing on expanding its logistics services in the pulp, engineering projects, and automotive logistics sectors[127]. Corporate Governance - The company is committed to improving corporate governance, having revised multiple internal regulations and successfully completed board restructuring in 2025[139]. - The company held 2 shareholder meetings and 11 board meetings in 2025, ensuring compliance with regulatory requirements[139]. - The company actively engages with investors through various channels, enhancing communication and market recognition[140]. - The company is committed to maintaining transparency in its financial reporting and governance practices, as evidenced by the detailed disclosure of compensation for its executives[143]. - The company has a diverse leadership team with backgrounds in economics, management, and engineering, which supports its strategic objectives[145]. Social Responsibility - The company made a one-time donation of 3 million yuan to the COSCO Shipping Charity Foundation for social welfare projects[181]. - A total of 1.637 million yuan was invested in poverty alleviation and rural revitalization projects, benefiting approximately 300,000 people[184]. - The company allocated 400,000 yuan for the construction of a women's and children's activity center in Anhua County, supporting over 100 local talents through training programs[186]. - The company contributed 350,000 yuan to support the construction of key projects in Yingde, including a bridge and road improvements, benefiting over 500 households[186]. - The company is committed to fulfilling its social responsibility by addressing urgent needs in the communities it serves[186]. Human Resources - The total number of employees in the company is 5,548, with 3,809 crew members and 1,739 shore-based personnel[162]. - The company conducted training programs with a total participation of 5,365 person-times, achieving an average of 111.51 hours of training per person, with a coverage rate of 100% for headquarters staff[168]. - The total remuneration paid for labor outsourcing amounted to RMB 1,226,954,830.95[169]. - The company has implemented a performance assessment and incentive mechanism for its management team, linking compensation to performance outcomes[177]. Investment and R&D - The company invested CNY 4 million in various livelihood projects, enhancing safety and living conditions for over 3,000 people in the community[187]. - The company is investing $50 million in R&D for new technologies aimed at enhancing user experience[146]. - The company invested 95,640,943.52 RMB in R&D, representing 0.41% of total revenue, with no capitalized R&D expenses[88]. - The company had 250 R&D personnel, making up 4.97% of the total workforce, with 73 holding master's degrees and 3 holding doctoral degrees[89]. Related Party Transactions - The company committed to avoiding competition with its controlling shareholder, China COSCO Shipping Group, ensuring no harm to the interests of other shareholders[192]. - The company will minimize related party transactions with its subsidiaries and ensure they are conducted at fair market prices[193]. - The company guarantees that any related party transactions will be necessary, reasonable, and fair, maintaining compliance with relevant laws and regulations[193].

Dividend Distribution - The company plans to distribute a cash dividend of 1.30 RMB per 10 shares, totaling approximately 59.4 million RMB, which represents 11.19% of the net profit attributable to ordinary shareholders[7]. - The total cash dividend amount (including tax) is CNY 59,398,981.46, which accounts for 11.19% of the net profit attributable to ordinary shareholders in the consolidated financial statements[199]. - The total cash dividend amount, including share buybacks, is CNY 60,398,751.46, representing 11.37% of the net profit attributable to ordinary shareholders[199]. - The company has confirmed that the cash dividend policy complies with the company's articles of association and shareholder resolutions[197]. - The company has established a three-year shareholder dividend return plan for 2024-2026, approved by the board and shareholders[196]. - The number of bonus shares distributed per 10 shares is 0, indicating no stock dividends are planned[199]. - The company has not proposed a cash profit distribution plan for the reporting period, as it is not applicable[198]. - The independent directors have fulfilled their responsibilities and played their expected roles in the decision-making process regarding dividends[197]. Financial Performance - The company's operating revenue for 2025 reached ¥4,167,918,226.01, representing an increase of 11.64% compared to ¥3,733,285,492.02 in 2024[24]. - The total profit for 2025 was ¥579,882,299.61, up by 11.26% from ¥521,186,712.63 in 2024[24]. - The net profit attributable to shareholders for 2025 was ¥531,023,072.22, reflecting a significant increase of 20.53% from ¥440,578,959.24 in 2024[24]. - The net cash flow from operating activities for 2025 was ¥415,858,356.77, which is a 52.73% increase compared to ¥272,280,080.77 in 2024[24]. - The company's total assets at the end of 2025 amounted to ¥9,282,233,645.70, a 16.75% increase from ¥7,950,716,228.10 at the end of 2024[24]. - The basic earnings per share for 2025 was ¥1.17, an increase of 17.00% from ¥1.00 in 2024[25]. - The weighted average return on equity for 2025 was 11.17%, an increase of 0.46 percentage points from 10.71% in 2024[25]. - The company reported a net profit of ¥196,679,474.68 in Q4 2025, which is the highest quarterly profit for the year[27]. - Non-recurring gains for 2025 totaled ¥6,091,315.10, compared to ¥43,919,822.03 in 2024[28]. - The company's net assets attributable to shareholders at the end of 2025 were ¥5,155,833,558.04, a 19.86% increase from ¥4,301,600,979.34 at the end of 2024[24]. Audit and Compliance - The company has received a standard unqualified audit report from Tianjian Accounting Firm[6]. - The board of directors has confirmed the accuracy and completeness of the annual report, taking legal responsibility for its content[4]. - There are no non-operating fund occupations by controlling shareholders or related parties[9]. - The company has not faced any violations in decision-making procedures regarding external guarantees[9]. - The company ensures compliance with shareholder meeting regulations, allowing all shareholders, especially minority shareholders, to exercise their rights effectively[169]. - The board of directors operates in accordance with the company's articles of association, ensuring objective and scientific decision-making to protect the interests of all shareholders[170]. - The company adheres to strict information disclosure regulations, ensuring timely and accurate reporting to stakeholders[170]. - There are no significant differences in corporate governance compared to regulatory requirements, indicating strong compliance[172]. - The company has not engaged in any related party transactions that could harm its independence or shareholder interests[171]. Market and Industry Position - The company focuses on power conversion technology, with core product platforms including small and medium power converters, megawatt-level low-voltage converters, and medium-voltage converters[36]. - In the wind power sector, the company offers a range of products including doubly-fed converters and full-power converters, with power ratings from 1.5MW to 20.0MW[37]. - In the photovoltaic sector, the company provides competitive solutions including string inverters ranging from 3kW to 350kW and centralized inverters from 500kW to 3.125MW[41][42]. - The energy storage solutions include storage converters (PCS) with power ratings from 145kW to 3.45MW, achieving various domestic and international certifications[43][44]. - The company has developed a comprehensive range of high-performance drive inverters, covering power ratings from 0.75kW to 102MVA, suitable for various industrial applications[45]. - Hezhong Electric is the first domestic manufacturer to apply 12MW medium-voltage three-level IGCT inverters in metallurgical high-line rolling mills, achieving significant market penetration[46]. - The company has successfully developed the world's first 220-ton pure electric dump truck drive system, contributing to green mining construction[47]. - In the hydrogen energy sector, Hezhong Electric offers a series of IGBT hydrogen production power products ranging from 500kW to 20MW, including high-efficiency SiC hydrogen power supplies[49]. - The company’s large-capacity power products cover voltage ranges from 400V to 35kV and capacities from 500kVA to 100MVA, supporting further parallel expansion[51]. - Hezhong Electric's SVG products range from 500kVar to 70MVar, effectively stabilizing grid voltage and improving power factor, widely used in various sectors[52]. Research and Development - The company has established a matrix-based R&D structure, enhancing collaboration and resource sharing across various business units, which significantly improves development efficiency and quality[87]. - The R&D team consists of 812 engineers, with 32.39% holding a master's degree or higher, ensuring high technical competence[89]. - The company has filed 231 patent applications in 2025, with 99 patents granted, including 20 invention patents, reflecting its strong commitment to innovation[94]. - The company has achieved significant technological advancements, including the first global compliance certification for grid-forming inverters in January 2023, and has launched large-scale demonstration projects in wind and solar energy[91]. - The company is committed to building a comprehensive energy management system for hydrogen production, integrating renewable energy sources for efficient and stable hydrogen generation[155]. - The company is developing high-capacity, multifunctional, and high-precision power systems for renewable energy applications, including grid-connected and off-grid testing power systems[158]. - The company aims to improve the adaptability and performance of its products through continuous optimization and innovation in technology and application scenarios[156]. - The company is focusing on technological innovation and market expansion to enhance its competitive edge in the renewable energy sector[146]. Strategic Initiatives - The company is actively expanding its product offerings in various sectors, including oil and gas, mining machinery, and large test benches, to enhance its competitive edge[48]. - The company is expanding its management team with new appointments and elections to enhance governance[182]. - The company plans to expand its market presence through strategic partnerships and potential acquisitions to drive growth[177]. - The company aims to enhance its market share in the solar storage, transmission, and hydrogen energy sectors, leveraging its brand influence in the wind power industry[159]. - The company is implementing a digital transformation plan, including the integration of SRM and MES systems to improve supply chain efficiency and production management[161]. Risks and Challenges - The company is facing risks related to policy changes in the renewable energy sector, which could impact market demand for its products[162]. - The average selling price of the company's products is declining, which poses a risk to its gross margin if not managed effectively[164]. - The company is experiencing a significant increase in accounts receivable, which may lead to risks associated with bad debts and slower turnover rates[165]. - The company is at risk of losing tax incentives that significantly impact its net profit if it fails to maintain its status as a high-tech enterprise[165]. - The company is exposed to fluctuations in raw material prices, particularly for copper, aluminum, and silver, which can affect its overall profitability[165]. Employee and Governance - The company has a total of 2,562 employees, with 839 in the parent company and 1,723 in major subsidiaries[191]. - The professional composition includes 1,020 technical personnel, 767 production personnel, and 224 sales personnel[191]. - The company has implemented a competitive and fair salary policy, with salaries based on position, responsibilities, and performance contributions[192]. - The training plan is aligned with the company's development strategy, focusing on departmental training needs and employee levels[194]. - The total actual remuneration for all directors and senior management at the end of the reporting period amounted to CNY 1,550.44 million[181]. - The remuneration scheme for directors and senior management for 2025 has been approved by the board and is aligned with the company's performance and industry standards[181]. - The independent directors' allowances are not subject to performance assessments, while non-independent directors' remuneration is based on performance evaluations[181]. - The company has no deferred payment arrangements for the remuneration of non-independent directors and senior management as of the end of the reporting period[181].

Financial Performance - The company reported a net profit for the year 2025 primarily due to a one-time investment gain from the transfer of subsidiary equity, but the consolidated financial statements still show a loss[6]. - The board has proposed no profit distribution for 2025, considering the non-sustainable nature of the profit and the need for future funding[6]. - The net profit attributable to shareholders for 2025 was a loss of CNY 208.81 million, improving from a loss of CNY 4.66 billion in 2024[20]. - The company's operating revenue for 2025 was CNY 77.52 billion, a decrease of 5.25% compared to CNY 81.82 billion in 2024[20]. - The company reported a total of CNY 19.91 million in non-recurring gains and losses for 2025, a significant recovery from a loss of CNY 360.73 million in 2024[26]. - The cumulative net profit over the last three accounting years averaged -22.17 billion RMB, indicating a challenging financial performance[179]. Cash Flow and Investments - The net cash flow from operating activities increased significantly by 332.06% to CNY 4.15 billion in 2025, compared to CNY 960.87 million in 2024[20]. - Investment cash outflow decreased by 46.68%, mainly due to last year's subsidiary's purchase of time deposit products, while this year's time deposit balance remained stable[52]. - The company achieved a net cash inflow from operating activities of RMB 4.152 billion, a 332.06% increase year-on-year[50]. - The company’s total investment amount at the end of the reporting period was RMB 14,669 million, reflecting an increase of 11.67% compared to the previous year[3]. Operational Efficiency - The company’s logistics costs were reduced by RMB 6 per ton year-on-year, and quality costs were controlled at RMB 9.1 per ton[41]. - Operating costs decreased by 11.12%, primarily due to the company's ongoing cost reduction efforts and a year-on-year decline in raw material prices such as iron ore and coking coal[52]. - The company’s labor productivity reached RMB 533,900 per person per year, reflecting enhanced efficiency[42]. - The company’s restructuring efforts included reducing the number of functional departments from 15 to 9, enhancing operational efficiency[38]. Market and Product Development - The company aims to expand its market presence and enhance its product offerings in the steel industry, targeting key sectors and national projects[32]. - The company’s main business includes the production and sale of steel products, with a focus on high-end products used in various industries such as aerospace and construction[32]. - The company is focusing on enhancing product competitiveness in the special steel sector, aiming to become a leading player in the industry[110]. - The company’s new product sales grew by 16%, with a gross profit of RMB 353 per ton, highlighting successful innovation efforts[40]. Risk Management - The company does not face any significant risks that require special attention from investors[8]. - The management has analyzed the main risks faced by the company in the future, which are detailed in the management discussion and analysis section[7]. - The company faces major risks including safety production risk, environmental protection risk, cash flow management risk, debt reduction risk, and asset loss risk from equity investments[113]. - The company has established a comprehensive risk and internal control management approach, with quarterly assessments of risks that may affect overall business objectives[137]. Corporate Governance - The company has revised its corporate governance structure, eliminating the supervisory board and enhancing the effectiveness of the board of directors[118]. - The board consists of six members, including one executive director and five independent non-executive directors as of the end of 2025[119]. - The company has implemented a rolling monthly and quarterly cash budget to identify funding gaps in advance[113]. - The company has established a credit control and collection mechanism to improve cash flow management and reduce overdue accounts[113]. Shareholder Engagement - The company actively engages with shareholders, allowing those holding 1% or more of shares to propose new resolutions and nominate director candidates[143]. - The company conducted three earnings calls and four investor strategy meetings in 2025, enhancing communication with investors[145]. - The company’s annual performance release on March 31, 2025, attracted over 160,000 views through live streaming[145]. - The company has established multiple communication channels with investors, including email, phone, and in-person meetings, to facilitate better engagement[145]. Environmental and Social Responsibility - The company has disclosed its 2025 Environmental, Social, and Governance (ESG) report, available on the Shanghai and Hong Kong Stock Exchanges[187]. - The company has a total investment of 1.85635 million RMB in social responsibility projects, benefiting over 20,000 individuals[188]. - Total investment in poverty alleviation and rural revitalization projects amounted to 684,000 CNY, with specific allocations including 300,000 CNY for fresh corn processing and 200,000 CNY for seedling factory projects[189][190][191]. - The initiatives benefited 11,075 individuals from Li Ji Village and Longtai Village, enhancing local employment and educational resources[189]. Future Outlook - The company aims to produce 18.83 million tons of pig iron, 20.97 million tons of crude steel, and 20.15 million tons of finished steel products in 2026[105]. - The company plans to achieve a research and development investment rate of 4.5%, targeting sales of new trial products at 1.67 million tons with an excess gross profit of 400 million RMB[108]. - The company is considering strategic acquisitions to bolster its market position, with potential targets identified in the technology sector[154]. - The company plans to optimize its product structure and resource allocation to enhance long-term sustainable development[106].

Financial Performance - The total operating revenue for 2025 reached ¥31.63 billion, an increase of 13.02% compared to ¥27.98 billion in 2024[22]. - The total profit for the year was ¥8.71 billion, reflecting a growth of 21.45% from ¥7.17 billion in the previous year[22]. - The net profit attributable to shareholders was ¥7.71 billion, up 21.69% from ¥6.34 billion in 2024[22]. - The net profit after deducting non-recurring gains and losses was ¥7.41 billion, a 20.00% increase from ¥6.18 billion in 2024[22]. - Cash flow from operating activities amounted to ¥11.24 billion, representing a significant increase of 51.36% compared to ¥7.42 billion in 2024[22]. - The net assets attributable to shareholders at the end of 2025 were ¥61.27 billion, a 34.61% increase from ¥45.52 billion at the end of 2024[22]. - Total assets at the end of 2025 reached ¥69.87 billion, marking a 39.36% increase from ¥50.14 billion in 2024[22]. - Basic earnings per share increased by 19.00% to CNY 1.19 in 2025 from CNY 1.00 in 2024[24]. - The company reported a net cash flow from operating activities of CNY 4.810 billion in the third quarter of 2025[28]. - The company reported a significant increase in financing activities, with net cash flow from financing activities rising by 601.85% to ¥7.78 billion, primarily due to the issuance of H shares[158]. Research and Development - The company has a diverse R&D pipeline in oncology, metabolic and cardiovascular diseases, and neuroscience, focusing on unmet clinical needs[36]. - The company aims to develop multi-target therapies and combination sequential therapies to achieve high response rates and long-lasting efficacy[37]. - The company has established a comprehensive electronic project management platform that covers the entire drug development cycle, from target discovery to real-world data presentation[40]. - The company has submitted IND applications for several candidates after thorough preclinical validation, indicating a strong commitment to regulatory compliance[42]. - The company is actively conducting clinical trials at qualified medical institutions, ensuring adherence to GCP standards and monitoring product safety and efficacy[42]. - The company has a structured approach to clinical trial design and management, ensuring high data quality and regulatory compliance throughout the process[42]. - The company has established a comprehensive quality management policy covering all aspects of raw material procurement and production, ensuring compliance with GMP standards[46]. - The company has implemented a digital supplier relationship management system to manage the entire lifecycle of raw material procurement[46]. - The company has a strong emphasis on research in oncology, metabolic and cardiovascular diseases, and neuroscience, with a significant number of candidates targeting these areas[38]. - The company has 28 self-developed innovative molecules entering clinical stages, covering various disease treatment areas including oncology and chronic diseases[80]. Product Development and Pipeline - The company has a robust pipeline with a healthy cycle of products in various stages of development, ensuring a continuous flow of innovative solutions[184]. - The company is developing multiple drug candidates targeting various conditions, including SHR-1819 for chronic spontaneous urticaria and SHR-1139 for ulcerative colitis, both in China[119]. - The company is focusing on expanding its oncology portfolio with several combination therapies in development, including those targeting PD-L1 and HER2[102]. - The company is developing new formulations, such as oral GLP-1 for obesity and injectable GLP-1 for type 2 diabetes[101]. - The company is exploring treatments for autoimmune diseases, with candidates like SHR-2173 for lupus nephritis and systemic lupus erythematosus[103]. - The company is targeting rare diseases with specific therapies, including HRS-5965 for IgA nephropathy[102]. - The company is committed to addressing unmet medical needs in pediatric populations with drugs like SHR-1819 for atopic dermatitis[102]. - The company is leveraging advanced technologies in drug development, including ADCs (antibody-drug conjugates) for targeted cancer therapies[102]. - The company has multiple ongoing clinical trials for innovative drugs targeting various cancers, including HER2-positive metastatic breast cancer and advanced non-small cell lung cancer[107]. - The company is developing a combination therapy for first-line treatment of small cell lung cancer and advanced liver cancer, with trials ongoing in China[108]. Market Expansion and Strategy - The company is committed to global expansion and exploring innovative international cooperation models to benefit patients worldwide[50]. - The company is actively pursuing market expansion strategies in China, focusing on innovative therapies for chronic and complex diseases[101]. - The company is exploring opportunities for market expansion and potential mergers and acquisitions to strengthen its position in the pharmaceutical industry[58]. - The company has established a clinical research and collaboration center in Boston, USA, and has initiated multiple overseas clinical trials across Phases I to III[85]. - The company has completed 12 overseas business expansion transactions in 2023, with a potential total transaction value exceeding $27 billion, enhancing its global influence and industry recognition[153]. - The company is actively exploring partnerships with leading global pharmaceutical companies to maximize the commercial value of its products[153]. - The company is committed to aligning its strategies with national policies that promote innovation and support for new drug development[60]. - The company has received approval for multiple new drugs targeting various cancers, including HER2-positive breast cancer and advanced non-small cell lung cancer (NSCLC) with specific genetic mutations[54]. - The company is expanding its product line with new treatments for chemotherapy-induced nausea and vomiting, targeting patients undergoing highly emetogenic chemotherapy[54]. - The company is focusing on enhancing patient outcomes through targeted therapies and personalized medicine approaches in oncology[55]. Regulatory and Compliance - The company has successfully passed compliance management system certifications, becoming one of the first in the pharmaceutical industry to achieve this[73]. - The company has received over 70 regulatory designations for expedited pathways, including 9 from the US and Europe, enhancing its global clinical trial capabilities[146]. - The company has submitted 15 new drug/new indication applications (NDA/BLA) during the reporting period, indicating a strong pipeline of innovative products[126]. - The company has published 1,027 peer-reviewed papers in top international journals, with a cumulative impact factor of approximately 8,043 during the reporting period[126]. - The company has established a strong end-to-end clinical development capability, covering over 5,000 clinical researchers and conducting more than 400 clinical trials for over 100 innovative drugs[145]. Talent and Organizational Development - The company successfully recruited 660 core talents by 2025, with over 200 holding master's or doctoral degrees from renowned institutions, significantly enhancing its international and high-potential talent reserve[94]. - The company is committed to building a global talent pipeline through systematic campus recruitment projects, increasing the proportion of talents with overseas education backgrounds[94]. - The company has launched various employee activities and leadership forums to strengthen corporate culture and enhance organizational cohesion[96]. - The company is focused on accelerating internal talent development through targeted training programs for different levels of key personnel[94]. - The company has established a dual-channel career development and long-term incentive plan to reward high performers continuously[96]. Industry Trends and Challenges - The pharmaceutical industry in China is characterized by high investment, high risk, and strict regulation, with rapid growth driven by increasing healthcare demand and aging population[58]. - The competitive landscape in the pharmaceutical industry remains challenging, with increasing market saturation and the need for differentiation in product offerings[58]. - The government has emphasized the importance of the biopharmaceutical industry, implementing policies to support innovation and high-quality development in the sector[59]. - The demand for innovative treatment solutions in metabolic disorders is increasing due to the need for better efficacy and safety profiles[132]. - The global dementia patient population is estimated to be 58.3 million in 2023, with Alzheimer's disease accounting for 60% to 70% of these cases, highlighting a critical need for disease-modifying therapies[136].

Financial Performance - The company's operating revenue for 2025 was CNY 5,173,318,804.18, a decrease of 40.22% compared to CNY 8,653,460,677.96 in 2024[21] - The total profit for 2025 was CNY 215,427,739.80, down 24.64% from CNY 285,849,563.06 in 2024[21] - The net profit attributable to shareholders for 2025 was CNY 182,111,732.90, a decline of 24.57% from CNY 241,419,244.57 in 2024[21] - The net profit after deducting non-recurring gains and losses for 2025 was CNY 133,824,712.82, down 22.71% from CNY 173,151,766.76 in 2024[21] - Basic earnings per share decreased by 24% to CNY 0.38 from CNY 0.50, while diluted earnings per share also fell by 24% to CNY 0.38 from CNY 0.50[23] - The weighted average return on equity dropped by 0.87 percentage points to 2.49% from 3.36%[23] - The company reported a significant reliance on major customers, with the top five customers accounting for 57.62% of total sales, including 47.67% from related parties[59] - The company’s total liabilities decreased by 33.70% in accounts payable, amounting to ¥1,043,782,943.56[68] Cash Flow and Assets - The net cash flow from operating activities for 2025 increased by 56.51% to CNY 993,158,286.35 from CNY 634,563,347.35 in 2024[21] - The net assets attributable to shareholders at the end of 2025 were CNY 7,372,892,195.49, an increase of 1.33% from CNY 7,276,468,435.55 at the end of 2024[21] - The total assets at the end of 2025 were CNY 9,792,573,110.59, a decrease of 7.78% from CNY 10,618,963,806.74 at the end of 2024[21] - The company achieved a cash and cash equivalents balance of CNY 3.29 billion at the end of the period, a 286.83% increase year-on-year[48] - The company reported a net cash flow from operating activities of ¥993,158,286.35, representing a 56.51% increase compared to the previous year[66] Dividends and Shareholder Returns - The company plans to distribute a cash dividend of CNY 1.60 per 10 shares, totaling CNY 76,508,966.72, which represents 42.01% of the net profit attributable to shareholders for 2025[4] - The cumulative cash dividend amount is CNY 296,472,246.04, with a cash dividend ratio of 123.37% of the average annual net profit[146] - The proposed cash dividend for 2025 is RMB 1.60 per 10 shares, representing 42.01% of the net profit attributable to shareholders[160] Market and Industry Conditions - In 2025, the overall cement market in China experienced a decline in volume and weak pricing, leading to pressure on profitability due to ongoing adjustments in the real estate market and a slowdown in fixed asset investment[41] - The average national cement market price in 2025 is expected to be 367 RMB/ton, down 17 RMB/ton or 4.4% compared to the previous year[84] - The construction industry is facing challenges, with national fixed asset investment declining by 3.8% year-on-year, and real estate development investment down by 17.2%[72] - The company is facing risks from market competition, rising costs, and stringent environmental policies, which could impact its market share and profitability[108][109][110] Operational Strategies and Innovations - The company operates in the cement and digital logistics sectors, focusing on infrastructure and real estate construction[33] - The digital logistics platform aims to enhance logistics efficiency and reduce costs for enterprises by providing intelligent management solutions[34] - The company has implemented technology upgrades and smart factory initiatives to improve energy efficiency in cement production[33] - The company has accumulated 410 patents through independent research and technological innovation, enhancing its operational efficiency and cost reduction[43] - The company is focusing on optimizing marketing strategies and product structures to enhance operational efficiency and reduce costs amid a challenging market environment[52] Subsidiary Performance - In 2025, the company's wholly-owned subsidiary Ningxia Saima achieved operating revenue of CNY 499.65 million, a year-on-year increase of 6.66%, with net profit rising by 401.28% to CNY 127.69 million[94] - The company's subsidiary Qingshui Co. reported operating revenue of CNY 582.22 million in 2025, up 14.93% year-on-year, with net profit increasing by 1.11% to CNY 57.71 million[95] - The subsidiary Zhongning Saima achieved operating revenue of CNY 111.49 million, a 3.40% increase year-on-year, while net profit surged by 2,075.62% to CNY 2.28 million[95] - The company’s subsidiary Gansu Cement achieved operating revenue of CNY 498.94 million, a 9.74% increase year-on-year, with net profit rising by 11.94% to CNY 91.27 million[97] Governance and Compliance - The company has maintained strict compliance with the Company Law and Securities Law of the People's Republic of China, ensuring a robust governance structure and effective internal control systems to mitigate operational risks[113] - The company has not experienced any significant defects in financial or non-financial internal controls as of the evaluation report date, indicating strong internal governance[114] - The company has implemented a governance structure that complies with regulatory requirements and has revised over 20 governance documents[162] - The company is committed to ensuring fair pricing and timely information disclosure for unavoidable related party transactions[166] Environmental and Social Responsibility - The company has disclosed its environmental, social, and governance (ESG) report for the year 2025, highlighting its commitment to sustainability[156] - The company has made a total social responsibility investment of CNY 627,000, including CNY 566,000 in cash donations and CNY 61,000 in material support[157] - The company has made donations to support impoverished communities, including CNY 31,000 for local aid and CNY 96,000 for poverty alleviation efforts[157] - The company donated RMB 3.6 million to the "Shan Jian Public Welfare" fund, benefiting 2 individuals[159] Future Outlook and Strategic Plans - The company plans to invest 1.04 billion RMB in new environmentally friendly cement production lines, replacing outdated capacity with advanced technology[89] - The company aims to enhance its digital logistics business and improve profitability through structural optimization and external business expansion[105] - The company plans to invest ¥500 million in R&D for new technologies over the next two years[120] - The company aims to achieve a 25% increase in production capacity by the end of the next fiscal year[122]

Financial Performance - The company's operating revenue for 2025 was ¥2,789,726,563.07, a decrease of 5.35% compared to ¥2,947,319,888.82 in 2024 [18]. - The net profit attributable to shareholders for 2025 was -¥166,106,537.56, an improvement of 16.44% from -¥198,781,739.51 in 2024 [18]. - The net cash flow from operating activities increased significantly by 374.47% to ¥318,516,461.42 in 2025, compared to ¥67,130,825.61 in 2024 [18]. - The total assets at the end of 2025 were ¥9,357,887,140.60, a decrease of 0.94% from ¥9,447,040,786.12 at the end of 2024 [18]. - The net assets attributable to shareholders decreased by 3.25% to ¥6,865,931,075.32 at the end of 2025, down from ¥7,096,883,870.60 at the end of 2024 [18]. - The company reported a basic earnings per share of -¥0.06 for 2025, an improvement of 14.29% from -¥0.07 in 2024 [18]. - The company achieved a revenue of 2,789.73 million yuan in 2025, a decrease of 5.35% compared to the previous year [70]. - The net profit attributable to shareholders was -166.11 million yuan, but this represented a 16.44% improvement from the previous year's loss [70]. Dividend Distribution - The company plans to distribute a cash dividend of 0.1 yuan per 10 shares to all shareholders, based on a total of 2,729,193,841 shares [4]. Globalization and Market Position - The company is undergoing a critical period of globalization and platform transformation, facing various risks including technological, market, and operational management risks [4]. - The company has established a global network with subsidiaries in regions such as North America, Europe, and Asia-Pacific, enhancing its international market presence since 2015 [31]. - Approximately 24.78% of the company's total revenue now comes from international operations outside mainland China, indicating a shift towards global market expansion [35]. - The company has become one of the leading providers of hotel information management systems globally, with over 90,000 hotels using its various subsystems [51]. - The company holds an approximately 80% market share in the five-star hotel segment in China, indicating its strong position in the high-end market [51]. Product Development and Innovation - The company is developing an AI engine aimed at enhancing operational efficiency and decision-making accuracy, with a completion target of December 2025 [113]. - The company is developing a new generation hotel management system platform called DAYLIGHT PMS-Pro, with a capitalized R&D amount of ¥200,396,883.10 [119]. - The company is focusing on refining software features to better serve clients in high-end hotel markets globally, including casino and leisure activity management modules [118]. - The company aims to enhance its product diversity and competitiveness through ongoing R&D projects [113]. - The company is transitioning from a software supplier to a service platform operator, actively promoting booking and payment platform services [161]. Strategic Partnerships and Client Acquisition - The company signed significant agreements with major hotel groups, including Marriott and InterContinental, marking a pivotal moment in its globalization strategy [68]. - The company has successfully signed contracts with major international hotel groups for its new cloud-based hotel management system, DAYLIGHT PMS, and has achieved large-scale deployment [43]. - The company has established a strong global management team with extensive experience in hotel management and information systems [66]. - The company has added 23 new group clients, bringing the total to 1,524, with a total of 35,586 client stores [86]. Research and Development - The number of R&D personnel is projected to decrease by 12.40% from 2,089 in 2024 to 1,830 in 2025, with a corresponding drop in the proportion of R&D personnel from 41.63% to 38.58% [118]. - R&D investment is expected to decline by 4.13% from ¥680,263,978.88 in 2024 to ¥652,195,891.86 in 2025, while the proportion of R&D investment to operating revenue will increase slightly from 23.08% to 23.38% [118]. - The company is closely monitoring AI technologies to integrate them into its cloud product upgrades [160]. Governance and Management - The board of directors has confirmed the accuracy and completeness of the annual report, ensuring no false records or misleading statements exist [3]. - The company has established a comprehensive internal control system covering operational management, financial management, and information disclosure, ensuring compliance with regulatory requirements [171]. - The company has a clear ownership structure, with all assets independently controlled and utilized, ensuring no asset occupation by the controlling shareholder [182]. - The company has a dedicated board secretary responsible for information disclosure, ensuring timely and accurate communication of significant events to investors [177]. Market Trends and Economic Outlook - By 2025, domestic tourism in China is expected to exceed 6.5 billion trips, with a 16% year-on-year growth, and total spending reaching 6.3 trillion yuan, a 9.5% increase [38]. - The retail sales of consumer goods in China are projected to surpass 50 trillion yuan in 2025, reflecting a 3.7% growth from the previous year, supporting economic recovery [38]. - The company has faced challenges due to a slowdown in the Chinese tourism and hotel industry, impacting revenue and net profit growth; it is now expanding its target customer base globally [161].

Financial Performance - The company's operating revenue for 2025 was ¥3,770,262,381.46, a decrease of 26.80% compared to ¥5,150,649,541.32 in 2024 [20]. - The net profit attributable to shareholders for 2025 was -¥19,309,187.30, representing a decline of 134.02% from ¥56,761,572.66 in 2024 [20]. - The cash flow from operating activities for 2025 was ¥215,187,892.54, a slight decrease of 0.55% compared to ¥216,372,032.05 in 2024 [20]. - The total assets at the end of 2025 were ¥5,884,546,972.75, down 7.63% from ¥6,370,533,959.03 at the end of 2024 [20]. - The basic earnings per share for 2025 was -¥0.02, a decrease of 140.00% from ¥0.05 in 2024 [20]. - The company reported a negative net profit after deducting non-recurring gains and losses for 2025, amounting to -¥2,659,538.25, down 103.58% from ¥74,357,022.17 in 2024 [20]. - The company experienced a total of ¥98,491,082.84 in non-main business income, accounting for 2.61% of total operating revenue in 2025 [21]. - The company reported a total of -¥16,649,649.05 in non-recurring gains and losses for 2025, compared to -¥17,595,449.51 in 2024 [27]. - The weighted average return on net assets for 2025 was -0.39%, a decrease of 1.55% from 1.16% in 2024 [20]. - The company indicated uncertainty regarding its ability to continue as a going concern, as the net profit for the last three accounting years has been negative [20]. Risk Management and Compliance - The company emphasized the importance of risk awareness regarding future plans and development strategies, indicating that forward-looking statements do not constitute substantial commitments to investors [5]. - The financial report is guaranteed to be true, accurate, and complete by the board of directors and senior management, ensuring accountability [5]. - The company’s financial statements are audited by Rongcheng Accounting Firm, ensuring compliance and reliability of financial reporting [19]. - The company has maintained effective internal controls over financial reporting, with no significant deficiencies identified as of the evaluation report date [130]. - The company has implemented a safety management system to enhance safety production management and employee behavior compliance [137]. - The company has established a value management system aimed at aligning market value with intrinsic value through transparent information disclosure and effective investor relations [92]. Operational Updates - The company has maintained its operational integrity and core business focus, despite external market challenges [5]. - The company’s registered address has changed, reflecting its operational adjustments and strategic positioning [16]. - The company experienced a fire incident in July 2025, leading to a production halt that affected 5.55% of the audited revenue for the fiscal year 2025 [33]. - The company successfully restored production after a fire incident in July 2025, with production systems returning to normal by December 2025 [45]. - The company has effectively integrated its supply chain from silicon powder processing to downstream silicone rubber, oils, and resins, enhancing cost control and risk resistance capabilities [39]. Research and Development - Research and development investment for the year was CNY 133 million, resulting in over 80 new product brands developed, with 40 achieving market application [47]. - The company has been granted 14 new patents in 2025, bringing the total number of effective patents to 103 [39]. - The company aims to enhance its production capacity and product quality through process technology upgrades, focusing on energy efficiency and sustainable production methods [76]. - The company plans to increase the proportion of high-end products in its overall product structure by investing in R&D and developing core technologies [77]. - The company will accelerate new product development, exploring applications in AI, electronics, and biomedicine, while expanding its product range to include silicone sealants and composite materials [78]. Market and Sales Strategy - The company is focusing on high-quality development in the organic silicon industry, transitioning from blind expansion to self-regulation and energy conservation [35]. - The company’s sales strategy focused on high-margin products in emerging sectors like photovoltaics and new energy vehicles, adapting to structural changes in market demand [47]. - The company is actively expanding its market presence in emerging economies, capitalizing on the growth opportunities in these markets [40]. - The company has established a comprehensive domestic and international marketing network, exporting products to over 30 countries, including the USA, Belgium, and the UAE [40]. - The company is recognized as a national high-tech enterprise and has received various honors, including being listed among the top 10 global silicone companies [43]. Governance and Shareholder Relations - The company has established a clear governance structure, with independent management and no subordination to controlling shareholders [99]. - The company has implemented a performance evaluation and incentive mechanism for directors and senior management, linking compensation directly to operational performance [97]. - The company has a total of 244,000 shares held by its directors and senior management, with no changes in shareholding during the reporting period [102]. - The company’s board includes experienced professionals, such as Mr. Wang Wei, who has held various leadership roles since 1982, and Mr. Zhang Zhefeng, a certified accountant with extensive financial management experience [104]. - The company has established a salary distribution system that reflects job value and is aligned with industry standards [121]. Environmental and Social Responsibility - The company emphasizes environmental protection and corporate social responsibility, aiming for sustainable and healthy development [97]. - The company received the "Shandong Province Clean Production Advanced Unit" honor, reflecting its commitment to environmental standards and zero wastewater discharge [45]. - The company has completed the construction of a safety skills training base and developed the "Silicon Material Cloud" APP for employee safety training, enhancing the safety literacy of grassroots employees [138]. - The company has integrated and improved its QEHS management system, conducting regular audits to ensure the implementation of safety measures and enhance safety awareness [139]. - The company is committed to fulfilling social responsibilities and contributing to a harmonious society [137]. Future Outlook - The company aims to achieve a revenue growth target of 10% in the next fiscal year, driven by increased demand for its products [184]. - The overall market outlook remains positive, with expectations of continued growth in the organic silicon materials sector [184]. - The company plans to distribute a cash dividend of RMB 0.15 per 10 shares, totaling RMB 18,000,000.00, based on a total share capital of 1,200,000,000 shares for the 2024 profit distribution proposal [124]. - The company has plans for future product launches and technological advancements to drive growth in the upcoming fiscal year [184]. - The company is exploring potential mergers and acquisitions to strengthen its market position and diversify its product offerings [184].

Corporate Governance - The company has optimized its governance structure, integrating supervisory functions into the board's audit committee to enhance governance efficiency [44]. - The board of directors consists of 9 members, including 3 independent directors, meeting legal and regulatory standards [116]. - The company has established specialized committees to improve decision-making processes, including a development strategy committee and an audit committee [116]. - The company has maintained independence from its controlling shareholder, ensuring no interference in its operations [115]. - The company has been actively engaging with shareholders, ensuring their rights to information and participation are upheld [114]. - The company is committed to transparency in its financial reporting and has been responsive to inquiries regarding its annual performance [111]. - The company is focused on enhancing its governance structure and internal control systems, ensuring compliance with regulatory requirements [113]. - The audit committee consists of 3 directors, including 2 independent directors, ensuring compliance with regulatory requirements [118]. - The company has established a robust internal audit system to effectively supervise daily operations and evaluate internal control effectiveness [120]. - The performance evaluation and incentive mechanism have been revised to enhance employee rights and improve overall efficiency [121]. Financial Performance - The company reported a significant increase in revenue, achieving a total of $1.2 billion for the fiscal year, representing a 15% year-over-year growth [104]. - The company reported a total revenue of 78.21 million CNY for the current period, with a significant increase compared to the previous year [144]. - The company reported a significant increase in net profit primarily related to non-operating activities, leading to discrepancies with cash flow from operations [71]. - The company reported a significant increase in revenue, achieving a total of $1.2 billion for the quarter, representing a 15% year-over-year growth [108]. - The company anticipates a positive cash flow of $100 million by the end of 2025, supporting future growth initiatives [102]. - The company achieved a gross margin of 9.90% for the reported period, indicating stable pricing strategies [192]. - The company has reported no significant issues with large sales returns during the reporting period [193]. - The company reported a financial expense of 28.1 million yuan due to related party debts [197]. Strategic Initiatives - The company plans to focus on high-quality development and strategic upgrades in 2026, aligning with the "14th Five-Year Plan" for sustainable growth [85][86]. - The company aims to deepen refined management and strengthen systematic construction and operational capabilities to achieve higher quality development [29]. - The company is committed to ongoing evaluations and assessments of drainage projects to ensure effectiveness and compliance with urban safety standards [59]. - The company is actively pursuing market expansion in Southeast Asia, targeting a 25% increase in regional sales [102]. - The company is exploring new strategies for customer engagement, aiming for a 15% increase in customer retention rates [102]. - The company is committed to sustainability, aiming for a 40% reduction in carbon emissions by 2025 [104]. - The company is focusing on market expansion strategies, particularly in the Pingshan area, with updates on July 10, July 19, and August 26, 2025 [105]. - The company is committed to building a robust security framework that adapts to IoT environments, thereby establishing a competitive edge in the market [63]. Risk Management - The company has detailed potential risks it may face in its annual report, particularly in the section discussing future development prospects [4]. - The company faces risks related to PPP project operations, including high capital investment and long payback periods, which could impact cash flow and operational stability [92]. - The company is experiencing market competition risks, with declining revenue in environmental services due to increased competition from larger state-owned enterprises and industry capital [93]. - The company is addressing policy risks by continuously monitoring regulatory changes and enhancing compliance capabilities to meet higher standards in environmental governance [95]. - The company is managing litigation risks by organizing a professional legal team to address increasing legal disputes and improve overall risk management [96]. Research and Development - The number of R&D personnel increased by 20.31% from 64 in 2024 to 77 in 2025, with the proportion of R&D personnel rising from 15.61% to 20.42% [66]. - Ongoing R&D investments are projected to reach $50 million in 2025, focusing on innovative technologies [102]. - The company has completed the development of a low-code rapid development platform, enhancing market responsiveness and reducing development costs [65]. - The company has completed the design and application of a smart control platform for procurement, facilitating online collaboration across the entire production process [65]. - The company has achieved significant milestones in technology development, including the application for an invention patent and software copyright related to zero-carbon mining technologies [62]. Shareholder Relations - The company plans not to distribute cash dividends, issue bonus shares, or increase share capital from reserves [5]. - The total compensation for all directors and senior management at the end of the reporting period amounted to 3.4287 million yuan [146]. - The company is committed to timely disclosure of any transactions that may affect shareholder interests, particularly for minority shareholders [173]. - The company has pledged to resolve competition issues with Shenzhen Huakong Saige Co., Ltd. within 5 years, utilizing methods such as asset restructuring and joint ventures [173]. Legal Matters - The company is involved in a significant arbitration case with a claim amount of 50 million RMB related to a lithium-ion battery project investment contract [186]. - The company is also facing another arbitration case regarding land compensation amounting to approximately 4,889.09 million RMB [186]. - The company has confirmed that the ongoing legal matters will not materially affect its current or future profits [186]. - The company has reported a total of 13 lawsuits as a plaintiff with a total amount involved of ¥5,148.33 million, which is not expected to have a significant impact on the company [188]. - As a defendant, the company is involved in 40 lawsuits with a total amount of ¥7,549.71 million, also not expected to significantly impact the company [188]. Operational Efficiency - The company achieved a 15-20% reduction in project costs through optimized construction techniques, improving overall economic efficiency [66]. - The company has implemented significant upgrades to the construction technology of energy-efficient aluminum alloy windows, improving construction efficiency and safety [66]. - The company reported a 10% reduction in operational costs due to efficiency improvements [102]. - The company has completed the upgrade of the construction service cloud platform 3.0, enhancing user experience and operational efficiency [61].

浙江凯恩特种材料股份有限公司 2025 年年度报告全文 浙江凯恩特种材料股份有限公司 2025 年年度报告 2026 年 3 月 1 浙江凯恩特种材料股份有限公司 2025 年年度报告全文 2025 年年度报告 第一节 重要提示、目录和释义 公司董事会及董事、高级管理人员保证年度报告内容的真实、准确、完 整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责 任。 | | | 浙江凯恩特种材料股份有限公司 2025 年年度报告全文 备查文件目录 （一）载有公司负责人、主管会计工作负责人、会计机构负责人（会计主管人员）签名并盖章的财务报表。 公司负责人刘溪、主管会计工作负责人杨照宇及会计机构负责人（会计 主管人员）郭晓彬声明：保证本年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 报告中如有涉及未来的计划、业绩预测等方面的内容，均不构成本公司 对任何投资者及相关人士的承诺，投资者及相关人士均应对此保持足够的风 险认识，并且应当理解计划、预测与承诺之间的差异。 公司在本报告第三节"管理层讨论与分析"之"十一、公司未来发展的 展望"描述了公司未来经营中可能面临的风险，敬 ...

赛诺医疗科学技术股份有限公司 2025 年年度报告 公司代码：688108 公司简称：赛诺医疗 赛诺医疗科学技术股份有限公司 2025 年年度报告 1 / 258 赛诺医疗科学技术股份有限公司 2025 年年度报告 重要提示 一、本公司董事会及董事、高级管理人员保证年度报告内容的真实性、准确性、完整性，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司上市时未盈利且尚未实现盈利 □是 √否 三、重大风险提示 公司已在本报告中详细阐述了公司在经营过程中可能面临的各种风险及应对措施，具体内 容详见本报告第三节"管理层讨论与分析之风险因素"部分的阐述，敬请投资者注意投资风险。 四、公司全体董事出席董事会会议。 五、立信会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 六、公司负责人孙箭华、主管会计工作负责人沈立华及会计机构负责人（会计主管人员）沈立 华声明：保证年度报告中财务报告的真实、准确、完整。 七、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 公司于 2026 年 3 月 24 日召开第三届董事会第十三次会议，审议通过"赛诺医疗科学技术 股份有限公司 ...